The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. Academic Article uri icon

Overview

abstract

  • We have studied the mechanisms by which the CC-chemokine RANTES can enhance the infectivities of human immunodeficiency virus type 1 (HIV-1) and other enveloped viruses, when present at concentrations in excess of 500 ng/ml in vitro. Understanding the underlying mechanisms might throw light on fundamental processes of viral infection, in particular for HIV-1. Our principal findings are twofold: firstly, that oligomers of RANTES can cross-link enveloped viruses, including HIV-1, to cells via glycosaminoglycans (GAGs) present on the membranes of both virions and cells; secondly, that oligomers of RANTES interact with cell-surface GAGs to transduce a herbimycin A-sensitive signal which, over a period of several hours, renders the cells more permissive to infection by several viruses, including HIV-1. The enhancement mechanisms require that RANTES oligomerize either in solution or following binding to GAGs, since no viral infectivity enhancement is observed with a mutant form of the RANTES molecule that contains a single-amino-acid change (glutamic acid to serine at position 66) which abrogates oligomerization.

publication date

  • August 1, 1999

Research

keywords

  • Chemokine CCL5
  • Glycosaminoglycans
  • HIV-1
  • Receptors, HIV
  • Signal Transduction

Identity

PubMed Central ID

  • PMC112716

Scopus Document Identifier

  • 0032768967

Digital Object Identifier (DOI)

  • 10.1128/JVI.73.8.6370-6379.1999

PubMed ID

  • 10400729

Additional Document Info

volume

  • 73

issue

  • 8